Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentora for breakthrough pain in chronic noncancer pain
NCT00228605Phase 3Completed
- Sponsor
- Cephalon, Inc.
- Start
- Mar 2005
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of fentanyl in breakthrough pain, sponsored by Cephalon, Inc. Primary endpoint: Safety and tolerability at 12 months. Started Mar 2005; status: completed.
02
Drugs
fentanyl
03
Conditions
breakthrough pain
Beyond the preview
Go deeper on NCT00228605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00228605.